| Line Item | 2023-02-28 | Y/Y |
|---|---|---|
| Revenue | $173K | — |
| R&D Expense | $17.3M | -37.5% |
| SG&A Expense | $20.4M | +59.7% |
| Operating Income | -$21.3M | +52.6% |
| Income Tax | $0 | — |
| Net Income | -$21.3M | +52.6% |
| Line Item | 2023-02-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $29.6M | -32.8% |
| Inventory | $727K | — |
| Current Assets | $36.4M | -30.1% |
| Total Assets | $40.6M | -31.5% |
| Current Liabilities | $3.6M | -63.6% |
| Long-term Debt | $3.6M | -1.6% |
| Total Liabilities | $6.8M | -48.4% |
| Line Item | 2023-02-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$34.9M | +18.8% |
| Capital Expenditures | $81K | -98.3% |
| Investing Cash Flow | $21.3M | +516.3% |
| Financing Cash Flow | $1.0M | -98.2% |
| Free Cash Flow | -$35.0M | +26.8% |
| Stockholders' Equity |
| $33.7M |
| -26.7% |